Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

IMPORTANCE: It is currently unclear whether chronic kidney disease (CKD)–associated cardiovascular risk in type 2 diabetes (T2D) is modifiable. OBJECTIVE: To examine whether cardiovascular risk can be modified with finerenone in patients with T2D and CKD. DESIGN, SETTING, AND PARTICIPANTS: Incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Rajiv, Pitt, Bertram, Rossing, Peter, Anker, Stefan D., Filippatos, Gerasimos, Ruilope, Luis M., Kovesdy, Csaba P., Tuttle, Katherine, Vaduganathan, Muthiah, Wanner, Christoph, Bansilal, Sameer, Gebel, Martin, Joseph, Amer, Lawatscheck, Robert, Bakris, George L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267848/
https://www.ncbi.nlm.nih.gov/pubmed/37314801
http://dx.doi.org/10.1001/jamacardio.2023.1505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267848/
https://www.ncbi.nlm.nih.gov/pubmed/37314801
http://dx.doi.org/10.1001/jamacardio.2023.1505

Ejemplares similares